These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1713091)

  • 1. Zinc therapy in children with cystic fibrosis.
    Safai-Kutti S; Selin E; Larsson S; Jagenburg R; Denfors I; Sten G; Kjellmer I
    Beitr Infusionsther; 1991; 27():104-14. PubMed ID: 1713091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis.
    Abdulhamid I; Beck FW; Millard S; Chen X; Prasad A
    Pediatr Pulmonol; 2008 Mar; 43(3):281-7. PubMed ID: 18214943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and red blood cell zinc in cystic fibrosis.
    Akanli L; Lowenthal DB; Gjonaj S; Dozor AJ
    Pediatr Pulmonol; 2003 Jan; 35(1):2-7. PubMed ID: 12461732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma zinc and growth status in preadolescent children with cystic fibrosis.
    Maqbool A; Schall JI; Zemel BS; Garcia-Espana JF; Stallings VA
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):95-101. PubMed ID: 16819384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Colombo C; Battezzati PM; Podda M; Bettinardi N; Giunta A
    Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis.
    Eubanks V; Koppersmith N; Wooldridge N; Clancy JP; Lyrene R; Arani RB; Lee J; Moldawer L; Atchison J; Sorscher EJ; Makris CM
    J Pediatr; 2002 Apr; 140(4):439-44. PubMed ID: 12006958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.
    Malvy DJ; Favier A; Faure H; Preziosi P; Galan P; Arnaud J; Roussel AM; Briançon S; Hercberg S
    Cancer Detect Prev; 2001; 25(5):479-85. PubMed ID: 11718454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.
    Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E
    Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients.
    Huseman CA; Colombo JL; Brooks MA; Smay JR; Greger NG; Sammut PH; Bier DM
    Pediatr Pulmonol; 1996 Aug; 22(2):90-5. PubMed ID: 8875581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cimetidine in children with cystic fibrosis: a randomized double-blind study.
    Schöni M; Kraemer R; Ruedeberg A; Lentze MJ; Mordasini RC; Riesen WF; Kläy MP; Rossi E
    Pediatr Res; 1984 Jan; 18(1):66-70. PubMed ID: 6366719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum zinc in patients with cystic fibrosis at diagnosis and after one year of therapy.
    Van Biervliet S; Van Biervliet JP; Robberecht E
    Biol Trace Elem Res; 2006 Sep; 112(3):205-11. PubMed ID: 17057259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients.
    Oudshoorn JH; Klijn PH; Hofman Z; Voorbij HA; van der Ent CK; Berger R; Houwen RH
    J Cyst Fibros; 2007 Jan; 6(1):35-40. PubMed ID: 16784903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study.
    Sharquie KE; Najim RA; Al-Salman HN
    Int J Dermatol; 2006 Jul; 45(7):857-61. PubMed ID: 16863527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.
    Sözmen EY; Kavakli K; Cetinkaya B; Akçay YD; Yilmaz D; Aydinok Y
    Biol Trace Elem Res; 2003 Jul; 94(1):79-86. PubMed ID: 12907830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
    Van Biervliet S; Devos M; Delhaye T; Van Biervliet JP; Robberecht E; Christophe A
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):109-15. PubMed ID: 18276127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
    Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
    Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.